10 in stock
Glutathione 1500 mg is a research-grade tripeptide attracting strong scientific interest for its central role in intracellular antioxidant defence, GSH/GSSG redox balance, mitochondrial protection, detoxification enzymes, protein signalling and cellular resilience under oxidative stress.
Glutathione is a naturally occurring tripeptide assembled from glutamate, cysteine and glycine. Its cysteine thiol group can donate reducing power, allowing glutathione to participate in antioxidant reactions, enzyme systems and reversible redox signalling throughout the cell.
The reduced form is abbreviated GSH. When two glutathione molecules become linked by a disulfide bond after oxidation, they form GSSG. Cells continually regulate these forms, and researchers often use their relationship as one indicator of the cellular redox environment.
Glutathione is often called the “master antioxidant.” That phrase captures its importance, but its real biology is more sophisticated: it operates as part of a coordinated network with glutathione peroxidases, glutathione reductase, glutaredoxins, NADPH and many other protective systems.
Glutathione peroxidase enzymes use GSH to reduce hydrogen peroxide and lipid hydroperoxides in carefully regulated reactions.
As GSH supplies reducing equivalents, two oxidized glutathione molecules can form the disulfide-linked state known as GSSG.
Glutathione reductase uses NADPH-derived reducing power to convert GSSG back toward reusable GSH.
Reversible S-glutathionylation can protect protein thiols and alter the activity of enzymes, receptors and signalling proteins.
The glutathione system helps cells control peroxides and reactive electrophiles before they disrupt lipids, proteins, membranes or DNA.
Mitochondrial glutathione supports peroxide metabolism, membrane integrity, iron-sulfur biology and survival signalling in the cell’s energy-producing compartment.
Glutathione S-transferases attach GSH to selected electrophilic compounds, supporting their metabolism and transport from cells.
S-glutathionylation can temporarily modify protein cysteines, helping researchers study how oxidative signals change cell behaviour without causing irreversible damage.
Immune-cell activation, proliferation and cytokine signalling are strongly influenced by redox state, making glutathione an important variable in immunology research.
GSH availability is studied across aging, exercise, environmental exposure, liver biology, neurobiology and tissue-recovery models involving oxidative stress.
| Research area | Encouraging observation | Evidence level | Important context |
|---|---|---|---|
| Cellular redox control | Extensive research identifies GSH as a major intracellular thiol involved in peroxide control, redox signalling and protection of protein cysteines. | Broad mechanistic evidence | Glutathione works within a larger antioxidant and metabolic network. |
| Mitochondrial homeostasis | Reviews describe mitochondrial GSH as central to peroxide metabolism, membrane protection, cell-death regulation and mitochondrial function. | Mechanistic and preclinical evidence | Mitochondria import GSH made elsewhere in the cell; transport and compartmental concentration matter. |
| Measured body stores | A six-month randomized, placebo-controlled study in healthy adults reported increased glutathione levels in several blood components and tissues after oral supplementation. | Human randomized trial | This was an oral-supplement study and does not establish equivalence with a vial, route or disease outcome. |
| Immune signalling | Research links glutathione and related thiol systems with immune-cell activation, differentiation, cytokine production and inflammatory control. | Cell, animal and review evidence | Effects depend on cell type, baseline redox state, timing and disease model. |
| Neurological research | A small randomized pilot of intravenous glutathione in Parkinson’s disease found the approach well tolerated and produced a non-significant signal that supported further study. | Small human pilot | The study was not powered to establish efficacy and does not support a treatment claim. |
| Oncology biology | Glutathione can protect normal cells from oxidative injury, while cancer researchers are also targeting GSH pathways that tumour cells may use for survival and drug resistance. | Mechanistic, preclinical and clinical-association evidence | Its oncology role is dual and context dependent—not a general anticancer benefit. |
Mitochondria produce ATP, but their electron-transfer reactions can also generate reactive oxygen species. A dedicated mitochondrial glutathione pool helps control this chemistry and supports enzymes that reduce peroxides before they damage membranes or metabolic proteins.
Mitochondria do not make their own glutathione. GSH synthesized in the cytosol must be transported into the organelle, where concentration, recycling capacity and membrane transport all shape the response to stress.
This compartment-specific biology has created positive research interest across neurodegeneration, metabolic stress, liver injury, aging and exercise-recovery models. It also explains why a total glutathione measurement cannot describe every cell compartment equally.
Glutathione has a genuine and well-characterized role in phase II metabolism. Glutathione S-transferase enzymes can conjugate GSH to selected electrophiles, reactive metabolic products and xenobiotic compounds. These reactions often make the resulting molecules easier for cells to transport and process.
That biochemistry supports extensive liver, toxicology and environmental-exposure research. However, it does not mean that glutathione indiscriminately “flushes toxins,” nor that every unwanted compound is handled through the same pathway.
A scientifically accurate description is that the glutathione system helps neutralize and conjugate specific reactive compounds through defined enzymes and transport systems.
Immune cells deliberately produce reactive molecules during signalling and host defence. Glutathione helps keep that chemistry within a functional range, while changes in intracellular GSH can influence activation, proliferation, differentiation and cytokine release.
This creates a promising but nuanced research picture. A depleted glutathione system may leave cells less able to regulate oxidative stress, whereas excessive suppression of reactive signals could interfere with normal signalling.
For that reason, researchers examine balance, compartment and timing rather than treating oxidation as universally harmful or antioxidant activity as universally beneficial.
Glutathione is not simply “good” or “bad” in oncology. In normal cells, the GSH system can protect proteins, membranes and DNA from oxidative injury. That protective biology is one reason it remains relevant to research on tissue stress and treatment-associated damage.
At the same time, many tumour cells increase glutathione synthesis, recycling or glutathione S-transferase activity. This can help them tolerate oxidative stress, maintain growth and neutralize some therapeutic compounds. High tumour-cell glutathione has therefore been associated with progression and treatment resistance in several research settings.
The strongest conclusion is that glutathione metabolism is an important oncology research target. Its effects depend on the cell type, tumour biology, redox environment and treatment context, so glutathione should never be presented as a stand-alone cancer treatment.
Glutathione has been studied in oral, liposomal, inhaled, intranasal and intravenous forms, as well as through precursor strategies intended to support endogenous synthesis. Each route has different absorption, metabolism, distribution and safety considerations.
Human findings from one route cannot automatically be transferred to another. Oral studies can inform questions about measured body stores, while intravenous or intranasal pilot studies investigate different exposure profiles. Neither establishes that a research vial will reproduce the same result.
The 1500 mg (1.5 g) designation identifies the amount of material associated with the vial. It is not a human dose, administration schedule, treatment protocol or statement of clinical effectiveness.
Reduced glutathione can oxidize with exposure to air, heat, light, metals or unsuitable pH. Controlled storage and handling improve experimental consistency.
Record lot, solvent, concentration, preparation time, temperature and storage duration because these variables can affect oxidation and stability.
A prepared solution is generally expected to be clear and free of visible particles unless product-specific documentation states otherwise.
Yes. Glutathione is a tripeptide composed of glutamate, cysteine and glycine. Its unusual γ-glutamyl bond helps distinguish it from many ordinary short peptides.
GSH is reduced glutathione. GSSG is the oxidized disulfide formed when two glutathione molecules link together. Their relationship is commonly used to study cellular redox conditions.
The nickname reflects its abundance and central role in peroxide control, redox signalling and antioxidant recycling. Still, glutathione does not work alone; it depends on enzymes, NADPH and other antioxidant systems.
Glutathione participates in defined enzymatic reactions that conjugate or neutralize selected reactive compounds. That is meaningful detoxification biochemistry, but it is not evidence for a universal “cleanse” or removal of every toxin.
Mitochondrial GSH supports peroxide metabolism, membrane protection and cell-survival signalling. Because mitochondria must import GSH, transport and compartmental concentration are major research variables.
No. It may protect normal cells from oxidative injury, but elevated glutathione systems can also help tumour cells survive and resist treatment. Oncology effects are highly context dependent.
No. It identifies the amount of material associated with the vial. It does not specify a dose, route, schedule or expected outcome.
A properly prepared solution is generally expected to be clear and free of visible particles unless the product documentation says otherwise. Unexpected cloudiness, particles or discolouration should be investigated.
Use gentle mixing unless a validated protocol directs otherwise. Vigorous shaking can introduce unnecessary air, foaming and oxidation variables.
Not automatically. Route and formulation change exposure, metabolism and safety. Evidence from oral, liposomal, inhaled, intranasal or intravenous research should be interpreted within the route that was actually studied.
Review the Canada Biogenix product page for current product details and availability.
Research and evidence notice: Glutathione 1500 mg is presented for laboratory research and scientific discussion. Findings involving antioxidant defense, mitochondrial biology, detoxification enzymes, immunity, recovery or oncology do not establish medical benefits for this product. This content is not medical advice, a dosing recommendation or an administration guide.
